The Scientist

» politics and disease/medicine

Most Recent

image: Different Cancers, Same Mutations

Different Cancers, Same Mutations

By | September 26, 2013

Scientists document common genetic alterations in cancers of different origins.

4 Comments

image: Citations Predict Nobel Winners?

Citations Predict Nobel Winners?

By | September 25, 2013

Thomson Reuters makes its annual data-based picks for which scientists could collect medals in Stockholm later this year.

0 Comments

image: Natural Opioids Linked to Chronic Pain

Natural Opioids Linked to Chronic Pain

By | September 19, 2013

The body’s own pain-quelling system may be at the root of chronic pain and symptoms of opioid withdrawal, according to a new study in mice.

0 Comments

image: Opinion: Rebuffing RAS Reform

Opinion: Rebuffing RAS Reform

By | September 19, 2013

On the impending changes to the Russian Academy of Sciences

0 Comments

image: Australia Loses Science Minister

Australia Loses Science Minister

By | September 18, 2013

For the first time since 1931, the incoming Prime Minister of Australia did not appoint a science chief.

0 Comments

image: The Price of DNA IDs

The Price of DNA IDs

By | September 16, 2013

Following natural disasters or violent political turmoil, DNA science can help identify victims. But what if a country can’t afford the technology?

0 Comments

image: Joint Projects Face Limits

Joint Projects Face Limits

By | September 9, 2013

An agreement between the U.S. and the U.K. on funding international collaborations is subject to political restrictions.

0 Comments

Contributors

By | September 1, 2013

Meet some of the people featured in the September 2013 issue of The Scientist.

0 Comments

image: Going Viral

Going Viral

By | September 1, 2013

Bacteriophages shuttle genes between diverse ecosystems.

1 Comment

image: Remaking a Classic

Remaking a Classic

By | September 1, 2013

Companies are bursting at the seams with tools to engineer pharma’s next magic bullet: the new and improved antibody.

0 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
AAAS